INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 431m ago
HOUSE PTR31m ago
SEC 13F31m ago
ROBINHOOD CHAIN31m ago
FC
Corporate insider

Freeman Chris

Chief Commercial OfficerCIK 0001871615

EDGAR filingsOpen in network
Disclosed transactions26
Buys / sells0 / 16
Max Insider Score53
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.24M
7,365 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Guardant Health, Inc.Chief Commercial Officer · Dec 8, 2025
36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL
$2.96M
17.4K sh
Aug 10, 2026
Aug 11, 2026
traded Aug 10, 2026
+1d
SEC FORM 4

Evidence

25
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$580K
3,463 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

16
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M$800K
28.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

23
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M$3.91M
35.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
35.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$6.00M
35.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
28.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
1,402 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
1,402 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

5
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Tax withholding
F$77K
594 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
24.4K sh
May 22, 2026May 26, 2026
traded May 22, 2026
+4dSEC FORM 4

Evidence

16
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M$802K
24.4K sh
May 22, 2026May 26, 2026
traded May 22, 2026
+4dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$2.90M
24.4K sh
May 22, 2026May 26, 2026
traded May 22, 2026
+4dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Grant or award
A—
18.7K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$24K
228 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

46
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$414K
4,084 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

53
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.22M
12.0K sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

46
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$353K
3,414 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

46
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$682K
6,555 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$42K
400 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$38K
372 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

39
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$76K
744 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

46
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$316K
2,964 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$25K
244 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$48K
478 sh
Dec 5, 2025Dec 8, 2025
traded Dec 5, 2025
+3dSEC FORM 4

Evidence